- Synonyms3-[[(4-Methyl-1-piperazin-yl)imino]methyl]rifamycin-13CD3; Abrifam-13CD3; Ba 41166/E-13CD3; Eremfat-13CD3; Famcin-13CD3; L 5103 Lepetit-13CD3; NSC 113926-13CD3; Refampicin-13CD3; Rifa-13CD3; Rifacap-13CD3; Rifadin-13CD3; Rifadine-13CD3; Rifaldazine-13CD3; Rifaldin-13CD3; Rifampicin SV-13CD3; Rifa...
- Description
3-[[(4-Methyl-1-piperazin-yl)imino]methyl]rifamycin-13CD3; Abrifam-13CD3; Ba 41166/E-13CD3; Eremfat-13CD3; Famcin-13CD3; L 5103 Lepetit-13CD3; NSC 113926-13CD3; Refampicin-13CD3; Rifa-13CD3; Rifacap-13CD3; Rifadin-13CD3; Rifadine-13CD3; Rifaldazine-13CD3; Rifaldin-13CD3; Rifampicin SV-13CD3; Rifampin-13CD3; Rifamycin AMP-13CD3; Rifaprodin-13CD3; Rifoldin-13CD3; Rifoldine-13CD3; Riforal-13CD3; Rimactan-13CD3; Rimactane-13CD3; Rimapen-13CD3; Sinerdol-13CD3; Tubocin-13CD3;
Rifampicin-13C-d3 is a fully characterized chemical compound used as a reference standard of API Rifampicin. The standard offered is compliant with regulatory guidelines. Rifampicin-13C-d3 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 13292-46-1 (non-labelled)